Silva Pharmaceuticals Limited announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was BDT 186.681 million compared to BDT 168.528 million a year ago. Operating income was BDT 44.524 million compared to BDT 33.316 million a year ago. Net income was BDT 33.522 million compared to BDT 22.132 million a year ago. Basic earnings per share was BDT 0.26 compared to BDT 0.22 a year ago. For the nine months, sales was BDT 557.262 million compared to BDT 517.397 million a year ago. Operating income was BDT 124.756 million compared to BDT 116.750 million a year ago. Net income was BDT 119.535 million compared to BDT 76.635 million a year ago. Basic earnings per share was BDT 0.97 compared to BDT 0.77 a year ago.